Hospital-onset Gram-negative Surveillance Program annual report, 2011.
The Australian Group on Antimicrobial Resistance performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2011 survey focussed on hospital-onset infections, examining isolates from all specimens presumed to be causing...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/35116 |
| _version_ | 1848754407314817024 |
|---|---|
| author | Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Pearson, J. Bell, J. Australian Group on Antimicrobial Resistance |
| author_facet | Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Pearson, J. Bell, J. Australian Group on Antimicrobial Resistance |
| author_sort | Turnidge, J. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | The Australian Group on Antimicrobial Resistance performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2011 survey focussed on hospital-onset infections, examining isolates from all specimens presumed to be causing disease. In 2011, 1,827 Escherichia coli, 537 Klebsiella species and 269 Enterobacter species were tested using a commercial automated method (Vitek 2, BioMérieux) and results were analysed using Clinical and Laboratory Standards Institute breakpoints from January 2012. Of the key resistances, non-susceptibilty to the third-generation cephalosporin, ceftriaxone, was found in 9.6% of E. coli and 9.5%-12.1% of Klebsiella spp. Non-susceptibility rates to ciprofloxacin were 10.6% for E. coli, 0.0%-8.3% for Klebsiella spp. and 0.0%-5.0% in Enterobacter spp. Resistance rates to gentamicin were 8.6%, 2.9%-10.9%, and 0.0%-15.6% for the same 3 groups respectively. Eight strains, 5 Klebsiella spp. and 3 Enterobacter spp. were shown to harbour a carbapenemase (IMP-4). |
| first_indexed | 2025-11-14T08:39:55Z |
| format | Journal Article |
| id | curtin-20.500.11937-35116 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T08:39:55Z |
| publishDate | 2014 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-351162017-01-30T13:47:45Z Hospital-onset Gram-negative Surveillance Program annual report, 2011. Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Pearson, J. Bell, J. Australian Group on Antimicrobial Resistance The Australian Group on Antimicrobial Resistance performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2011 survey focussed on hospital-onset infections, examining isolates from all specimens presumed to be causing disease. In 2011, 1,827 Escherichia coli, 537 Klebsiella species and 269 Enterobacter species were tested using a commercial automated method (Vitek 2, BioMérieux) and results were analysed using Clinical and Laboratory Standards Institute breakpoints from January 2012. Of the key resistances, non-susceptibilty to the third-generation cephalosporin, ceftriaxone, was found in 9.6% of E. coli and 9.5%-12.1% of Klebsiella spp. Non-susceptibility rates to ciprofloxacin were 10.6% for E. coli, 0.0%-8.3% for Klebsiella spp. and 0.0%-5.0% in Enterobacter spp. Resistance rates to gentamicin were 8.6%, 2.9%-10.9%, and 0.0%-15.6% for the same 3 groups respectively. Eight strains, 5 Klebsiella spp. and 3 Enterobacter spp. were shown to harbour a carbapenemase (IMP-4). 2014 Journal Article http://hdl.handle.net/20.500.11937/35116 restricted |
| spellingShingle | Turnidge, J. Gottlieb, T. Mitchell, D. Coombs, Geoffrey Pearson, J. Bell, J. Australian Group on Antimicrobial Resistance Hospital-onset Gram-negative Surveillance Program annual report, 2011. |
| title | Hospital-onset Gram-negative Surveillance Program annual report, 2011. |
| title_full | Hospital-onset Gram-negative Surveillance Program annual report, 2011. |
| title_fullStr | Hospital-onset Gram-negative Surveillance Program annual report, 2011. |
| title_full_unstemmed | Hospital-onset Gram-negative Surveillance Program annual report, 2011. |
| title_short | Hospital-onset Gram-negative Surveillance Program annual report, 2011. |
| title_sort | hospital-onset gram-negative surveillance program annual report, 2011. |
| url | http://hdl.handle.net/20.500.11937/35116 |